COSCIENS Biopharma Inc (CSCI)

[Spuds McKenz66]

no worries , in time we win AEZS

[Patrickwan1]

This company has been operating more than 30 years…many things too slow and losing competitive advantage!

[Patrickwan1]

I am afraid it is not about going down to 0.5, but RS, or going to pink and even delisted..

[Patrickwan1]

I am afraid no easy money. Progress too slow and value will be lost.

[livendi]

This is my fear also that it could go to 50 cents. I will load up if she goes down more. It’s easy money long term imo. God bless all

[Patrickwan1]

The next catalyst is by July 2022 if there is no delay. This we talk about 9-10 months! We most likely will face RS or even going to pink or delisted… very bad.

[Spuds McKenz66]

All good folks making coin , more powder on the way AEZS

[trickledownfacists]

Yup

[livendi]

yes and child test is for an unmet need$$$$

[at14tao]

Soooo, since AEZS hasn't delayed or postponed any milestones, confirmed yesterday they're right on track with P3 DETECT trial, you're saying AEZS has good management. Nice!!! LOL

[Patrickwan1]

A good management will always meet their own milestones. Company delaying milestones is not a good management! Nearest milestone now postponed till 9 months later, very bad.

[at14tao]

Still on track for July 2022 completion...

[livendi]

They already got the 5 mill from novo for that. It was when they adjusted the % of sales. Look it up. God bless all

[trickledownfacists]

A further $5 million will be paid if the FDA approves a pediatric indication for Macrilen, with Strongbridge funding 70% of the costs of a worldwide development program to make this happen.

[trickledownfacists]

Trial site updated. Enrolling, PR coming


https://clinicaltrials.gov/ct2/show/NCT04786873

[trickledownfacists]

Yup

[at14tao]

$25-30M might be considered pathetic, but it's growing and it comes with a $4M milestone payment. At $40M, AEZS licensing revenue % increases to 15% for sales over $40M. At $50M, they get a $10M milestone payment. I believe we're going to get that $25M milestone payment this year setting up 2022 to be a really big year with sales climbing and P3 DETECT completion with successful results.... I'm still a buyer....

[Patrickwan1]

Macrilen sales is pathetic, far below expectation and very bad for this only product which is selling..

[at14tao]

What??? Zero revenue??? LOL Keep'em coming.... LOL

[Spuds McKenz66]

bring it , keep shorting AEZS

[Spuds McKenz66]

they want 3500 for a puppy for mom , lets go AEZS

[Spuds McKenz66]

:) we r ok , if we hit 50 buy the heck out of it AEZS

[Spuds McKenz66]

its getting very interesting , very cheap pps AEZS

[Spuds McKenz66]

keep up champ Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the closing of its previously announced public offering of 20,509,746 common shares of Aeterna, at a price to the public of $1.45 per share. The gross proceeds from the offering were approximately $29.7 million, before deducting underwriting discounts, commissions and offering expenses payable by Aeterna.

[shimanoman]

Lol spuds is the only shareholder it seems! Lol
This is going to pink, or a huge RS

[shimanoman]

Value? What value? This is a speculative biotech with zero revenue, a share price almost 50% below nasdaq requirements that most likely with necessitate a massive reverse split to maintain their listing. Otherwise, the ONLY way this continues to trade is on the pinkies list.
So… what value are you referring to?

[livendi]

amen spuds

[Spuds McKenz66]

we r ok AEZS

[Spuds McKenz66]

dam 35 RSI geez la weez , maybe take a bite AEZS

[Spuds McKenz66]

u were smart but now u can take advantage when u r ready , whats the RSI at?

[Spuds McKenz66]

on the bottom of the ocean with block boots , someone bring me some air , AEZS is hold. I'm good... buying CLOV big time all will work out , revenues r increasing , we have time , I can wait and buy all day long , no problem

[Spuds McKenz66]

nice congrats , I'm holding off , will hold and will buy more later... AEZS

[Spuds McKenz66]

SWEET BABY JESUS AEZS

[livendi]

long term u are right meaning 6 months or more imo or right before delisting ,im sure we will get something,thats 3 months away however,in the end u will be right imo because aezs is set up for success with a low burn rate ,money in bank to last 2 more yrs, 68 mill i think rt now,and multiple different catalysts coming,some for unmet medical needs,its going to be a long 3-6 months though and this drop to 60 cents absolutely sucks,God bless all

[trickledownfacists]

Got $.58s today.

The value is insane.

[livendi]

I agree but other uses for macrilen and pedi test will be way more

[trickledownfacists]

Yup, they could go cash revenue positive next qtr.
Revenue is up 700% last qtr.

[at14tao]

I've said from the beginning it's about Macrilen sales and that's why I'm here. I have never hoped or believed in the quick COVID vaccine fantasy nor did I hear anything from AEZS that made me think that a oral vaccine pill wasn't years away. I would be happy with a COVID vaccine pump to $12 though...LOL

I have absolutely, and wrongly I might add, believed Macrilen sales would come faster and bigger, but Macrilen sales ARE picking up and it's looking like they're headed for around $25-30M this year. $13M so far... $40M in sales is the magic number. If sales growth continues, we'll hit that next year for sure. I see no upside in share price without some other positive news or until people start to believe Macrilen sales will pay the bills... Or another "miracle coming" pump and dump...LOL

[Patrickwan1]

Agree. AEZS is very BAD! A company with only 11 employees and we are hoping this company has miracle coming down!

[smile86]

No pay for PUMPER this week

[livendi]

the covid pill being so far off has killed us plain and simple,we knew other catalysts would take a while but klauss said 6 months ago we can do better than current vaccines,6 months later and they are just starting animal trials,how were spuds and me suppose to know know klauss meant in a couple of yrs,sma klauss,u mislead us,like i said a couple of days ago short term we are fd,sorry for our losses,imo this will go even lower till news hits which may be a while,with covid pill and other catalysts being so far away we are fd short term,cant do shit but wait for bottom and load up there,God bless all

[bobst2003]

All I kept hearing on here is all the cash they had on hand and how great shape they were in...

[bobst2003]

SPUDS, are u still in the green, u must have over a million shares from all your posts. Really thinking this stock is GARBAGE

[at14tao]

Macrilen sales...Macrilen sales...Macrilen sales!!!!
Raising all that cash by diluting shareholders by 100M shares over the last year and a half, from 19M OS to 121M OS, is now a major problem considering NASDAQ listing requirement issue, P3 DETECT trial not due for completion until H2 2022 and nothing else meaningful to report until H1 2023.
I'll say it again.... Macrilen sales...Macrilen sales...Macrilen sales!!!! Without Macrilen sales, no chance of SP going anywhere but down as they burn through all that cash....

[trickledownfacists]

Ha… nope

[livendi]

I hope so bro but I think we will touch 50 cents for sure. I hope im wrong

[trickledownfacists]

Bottom is in

[Patrickwan1]

Very BAD!

[livendi]

i dont think they were lying,maybe there was a problem orthey are trying to cover the dlta and other variants of covid,also covid isnt going anywhere,it will be almost like the flu shot,even people that have been vaccinated are getting it,the other catalysts are true also but again they are a yr out,was counting on covid pill to fill the gap till then,was wrong and it will probably test 50 cents,on the other hand when it does bottom out im buying a lot and will hold,just way too many catalysts coming and some for unmet needs,they have enuf cash till 2024 basically and the float is around 120 mill or so,they also have a low burn rate,forget about it going higher in the short term imo,the time will come whenit will push 5 or 10 bucks imo,problem is that time is probably 6 months to a yr away so till then it could get ugly,remember pedi test is for an unmet need and will sell better than adult test,also u know of the other preclincals trials they have going,again like ive always said the key is other uses for macrilen besides a test,again remember the 2 phase 3 in usa,approval of either 1 will be huge because eu and row will follow the fda like they did the adult test,again the problem is these are a yr out as is just about everything,going to take some time,its going be a long 6 months to a yr,God bless all

[Patrickwan1]

Professor Rudel of university of Wurburg said in March that Covid pill development would be fast because the concept had been used to develop similar process for prostate cancer vaccine which had been approved by authorities for clinical testing! It seems all are lies!